NCI at AACR COVID-19 and Cancer

TUESDAY, JULY 21

Thank you for joining NCI as we showcase our research and programs at the American Association for Cancer Research (AACR) COVID 19 and Cancer Virtual Meeting.

To view today’s presentations by NCI leaders and experts, register now! Learn more about NCI's presence at the meeting on our NCI at AACR COVID-19 and Cancer webpage.

Today: Dr. Lowy - When Cancer Research Goes Viral

Join NCI Principal Deputy Director Douglas Lowy, M.D., as he presents during Symposium 8: COVID-19 Diagnostics Development. During his presentation, titled “When Cancer Research Goes Viral,” Dr. Lowy will discuss how NCI has responded to the COVID-19 pandemic through research at the Frederick National Laboratory for Cancer Research, development of a serology network (SeroNet), development of a COVID-19 natural history study in patients with cancer (NCCAPS), and tracking of SARS-CoV-2 seroprevalence. In addition, Dr. Lowy will discuss how the COVID-19 pandemic may stimulate modified approaches to cancer screening moving forward.

Join this session Tuesday, July 21, 2:20-4:20 p.m. EDT

Tomorrow: Dr. Sharpless Addresses Closing Session

NCI Director Ned Sharpless, M.D., will address attendees during the closing roundtable session, titled Returning to Cancer Research During COVID-19. His presentation, “NCI’s Role in Ensuring Cancer Research Progress Amid a Pandemic,” will highlight how NCI has contributed scientific expertise to this public health crisis. He will share NCI’s efforts to quickly understand and navigate the impacts of COVID-19, particularly for cancer patients, which includes providing a variety of flexibilities in clinical trial operations. In addition, Dr. Sharpless will present the immediate effects that the pandemic is having on cancer research, as well as describe concerns about the potential effects on longer-term cancer outcomes.

The roundtable will include a panel discussion and Q&A.

Join this session on Wednesday, July 22, 4:35-6:00 p.m. EDT

Interested in Learning More About NCI's Role with COVID-19?

Visit the COVID-19 Research Initiatives webpage to see how NCI is contributing to the global effort to address the pandemic - including NCI-supported clinical trials, the NCCAPS study, SARS-CoV-2 Serology Research, genomic studies, and more.

Also, stay up-to-date on NCI Funding Announcements and Notices for COVID-19 to find opportunities as they become available.